SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-467372
Filing Date
2012-11-13
Accepted
2012-11-13 16:06:18
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d417515d10q.htm 10-Q 565479
2 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d417515dex311.htm EX-31.1 6001
3 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d417515dex321.htm EX-32.1 3153
  Complete submission text file 0001193125-12-467372.txt   3734868

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20120930.xml EX-101.INS 461152
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20120930.xsd EX-101.SCH 36711
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20120930_cal.xml EX-101.CAL 45869
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20120930_def.xml EX-101.DEF 185016
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20120930_lab.xml EX-101.LAB 306222
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20120930_pre.xml EX-101.PRE 216542
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-177498 | Film No.: 121198772
SIC: 2834 Pharmaceutical Preparations